Pain Treatment Evaluation in COVID-19 Patients with Hesitant Fuzzy Linguistic Multicriteria Decision-Making

G Didem Batur Sir1, Ender Sir2

  • 1Department of Industrial Engineering, Gazi University, Ankara 06570, Turkey.

Insights

Managing pain in COVID-19 patients is crucial. This study found paracetamol to be the most preferred treatment, followed by interventional methods, opioids, and NSAIDs, using a novel decision-making approach.

Area of Science:

  • Pain Management
  • Infectious Diseases
  • Decision Science

Background:

  • COVID-19 pandemic has led to widespread pain, often undertreated.
  • Effective pain management strategies are essential for patient recovery.
  • Selecting optimal pain treatments involves complex, conflicting criteria.

Purpose of the Study:

  • To guide physicians in selecting and ranking pain treatments for COVID-19 patients.
  • To address the challenge of multicriteria decision-making in pain management.
  • To introduce a robust methodology for evaluating treatment alternatives.

Main Methods:

  • Utilized a multicriteria decision-making framework.
  • Employed Hesitant Fuzzy Linguistic Term Sets (HFLTS) for expert input.
  • Integrated Analytic Hierarchy Process (AHP) for criteria weighting.
  • Applied Vise Kriterijumska Optimizacija I Kompromisno Resenje (VIKOR) for treatment evaluation.

Main Results:

  • Paracetamol identified as the most preferred pain treatment for COVID-19 patients.
  • Interventional treatments ranked second, followed by opioids.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) were ranked fourth.
  • The methodology minimized subjective expert bias in treatment selection.

Conclusions:

  • The developed AHP-VIKOR approach provides a structured method for pain treatment selection in COVID-19.
  • This approach enhances accuracy by mitigating subjective evaluations.
  • The methodology is adaptable for pain management in other patient and disease groups.